Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Morgenstern, Hal
Hafez, Hisham M.
Glazer, William M.
Giller, Earl
and
Zahner, Gwendolyn
1988.
Platelet Monoamine Oxidase activity and Tardive Dyskinesia.
Psychiatry Research,
Vol. 25,
Issue. 2,
p.
163.
Waddington, John L.
Brown, Katherine
O'Neill, Jane
McKeon, Patrick
and
Kinsella, Anthony
1989.
Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia.
Psychological Medicine,
Vol. 19,
Issue. 4,
p.
897.
Waddington, John L.
1989.
Vol. 31,
Issue. ,
p.
297.
Muscettola, Giovanni
Barbato, Giuseppe
de Bartolomeis, Andrea
Monteleone, Palmiero
and
Pickar, David
1990.
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
Psychiatry Research,
Vol. 33,
Issue. 3,
p.
259.
Inada, T.
Yagi, G.
Kamijima, K.
Ohnishi, K.
Kamisada, M.
Takamiya, M.
Nakajima, S.
and
Rockhold, R. W.
1990.
A statistical trial of subclassification for tardive dyskinesia.
Acta Psychiatrica Scandinavica,
Vol. 82,
Issue. 6,
p.
404.
Waddington, John L.
Youssef, Hanafy A.
and
Kinsella, Anthony
1990.
Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychological Medicine,
Vol. 20,
Issue. 4,
p.
835.
Barnes, Thomas R. E.
1990.
Movement Disorder Associated with Antipsychotic Drugs: The Tardive Syndromes.
International Review of Psychiatry,
Vol. 2,
Issue. 3-4,
p.
355.
Glazer, William M.
Morgenstern, Hal
Schooler, Nina
Berkman, Cathy S.
and
Moore, Daniel C.
1990.
Predictors of Improvement in Tardive Dyskinesia Following Discontinuation of Neuroleptic Medication.
British Journal of Psychiatry,
Vol. 157,
Issue. 4,
p.
585.
Mcclelland, H. A.
Metcalfe, A. V.
Kerr, T. A.
Dutta, D.
and
Watson, P.
1991.
Facial Dyskinesia: A 16–Year Follow-up Study.
British Journal of Psychiatry,
Vol. 158,
Issue. 5,
p.
691.
Glazer, William M.
Morgenstern, Hal
and
Doucette, John T.
1991.
The Prediction of Chronic Persistent Versus Intermittent Tardive Dyskinesia.
British Journal of Psychiatry,
Vol. 158,
Issue. 6,
p.
822.
Clarke, I. M.C.
1991.
Tardive dyskinesia and chronic pain.
Pain,
Vol. 45,
Issue. 2,
p.
167.
Brown, K. W.
and
White, T.
1992.
Sub-syndromes of tardive dyskinesia and some clinical correlates.
Psychological Medicine,
Vol. 22,
Issue. 4,
p.
923.
Kahn, E.Michael
Munetz, Mark R.
Davies, Marilyn A.
and
Schulz, S.Charles
1992.
Akathisia: Clinical phenomenology and relationship to tardive dyskinesia.
Comprehensive Psychiatry,
Vol. 33,
Issue. 4,
p.
233.
Bergen, Jenny
Kitchin, Rowena
and
Berry, Geoffrey
1992.
Predictors of the course of tardive dyskinesia in patients receiving neuroleptics.
Biological Psychiatry,
Vol. 32,
Issue. 7,
p.
580.
Liddle, Peter F.
Barnes, Thomas R. E.
Speller, Jeremy
and
Kibel, David
1993.
Negative Symptoms as a Risk Factor for Tardive Dyskinesia in Schizophrenia.
British Journal of Psychiatry,
Vol. 163,
Issue. 6,
p.
776.
Myers, Daniel E.
Schooler, Nina R.
Zullo, Thomas G.
and
Levin, Harry
1993.
A retrospective study of the effects of edentulism on the severity rating of tardive dyskinesia.
The Journal of Prosthetic Dentistry,
Vol. 69,
Issue. 6,
p.
578.
Quinlan, Donald M.
Schuldberg, David
Morgenstern, Hal
and
Glazer, William
1995.
Positive and Negative Symptom Course in Chronic Community-Based Patients.
British Journal of Psychiatry,
Vol. 166,
Issue. 5,
p.
634.
Raja, M.
and
Azzoni, A.
1996.
Tardive dystonia.
The Italian Journal of Neurological Sciences,
Vol. 17,
Issue. 6,
p.
409.
Nilsson, Agneta
Horrobin, David F
Rosengren, Annika
Waller, Lotte
Adlerberth, Annika
and
Wilhelmsen, Lars
1996.
Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933.
Prostaglandins, Leukotrienes and Essential Fatty Acids,
Vol. 55,
Issue. 1-2,
p.
83.
Peacock, L.
Lublin, H.
Gerlach, J.
and
Solgaard, T.
1996.
Clozapine versus typical antipsychotics a retro- and prospective study of extrapyramidal side effects.
Psychopharmacology,
Vol. 124,
Issue. 1-2,
p.
188.
eLetters
No eLetters have been published for this article.